Device Trial Radar · NCT04881162
Feasibility Study of the Treatment of Acute Ischemic Stroke Using the NOVIS Transcarotid Neuroprotection System
Last checked: Nov 21, 2026Latest source record: Jan 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
12
Actual
Start
Nov 2, 2021
Primary completion
Dec 11, 2023
Study completion Dec 11, 2023
Sponsor
- Lead sponsor
- Silk Road MedicalNot on our public-company list
- Sponsor type
- Industry
- First posted
- May 11, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study Objective is to establish the feasibility and safety of the NOVIS Transcarotid Neuroprotection System when used for the transcarotid intervention of patients that have a failed transfemoral endovascular therapy in the case of anterior circulation strokes due to large vessel embolic occlusions.
Conditions
- Acute Ischemic Stroke
Interventions
NOVIS Transcarotid Neuroprotection System (NPS)Device
The NOVIS Transcarotid Neuroprotection System (NPS) is intended to provide transcarotid vascular access and embolic protection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Device-related Serious Adverse EventsTime frame: 90 Days
2 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Yale University
New Haven, Connecticut
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.